Category: Pharmaceuticals
Global Pharmaceuticals
-
Ultraviolet Germicidal Irradiation (UVGI)
... reach US$1.2 Billion by 2030, growing at a CAGR of 11.3% over the analysis period 2023-2030. Air Disinfectant, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
-
Radiation Therapy Equipment
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. External Beam Radiation Therapy Equipment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach ... Read More
-
Medicated Skin Care Products
... reach US$9.2 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Medicated Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach ... Read More
-
Form Fill and Sealing (FFS) Equipment
... the year 2023, is expected to reach US$13.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Horizontal FFS Equipment, one of the segments analyzed in the report, is expected ... Read More
-
Ginseng
... of 10.2% over the analysis period 2023-2030. Asian Ginseng, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$11.2 Billion by the end of the analysis period. ... Read More
-
Foot Care Products
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by ... Read More
-
Neuromodulation
... of 9.1% over the analysis period 2023-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... reach US$944.9 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and ... Read More
-
Sodium Borohydride
... at a CAGR of 6.3% over the analysis period 2023-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$733.5 Million by the end of ... Read More
-
Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032
... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More
-
Contraceptives
... of 6.2% over the analysis period 2023-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$26.0 Billion by the end of the analysis period. ... Read More
-
Orthopedic Prosthetic Implants
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$14.9 Billion by ... Read More
-
Bariatric (Obesity) Surgical Devices
... reach US$5.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Clinical Trial Management Systems (CTMS)
... is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is expected to record a 15.0% ... Read More
-
Vertebral Compression Fracture Devices
... reach US$1.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Prenatal Diagnostics
... at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Empty Capsules Market Report by Type (Gelatin Capsule, Non-gelatin Capsule), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose (HPMC), and Others), Functionality (Immediate-release Capsules, Sustained-release Capsules, Delayed-release Capsules), Therapeutic Application (Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032
... Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032 The global empty capsules market size reached US$ 3.1 ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Companion Diagnostics
... at a CAGR of 2.1% over the analysis period 2023-2030. Companion Diagnostics Assay kits & Reagents, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$9.7 Billion ... Read More
-
e-Clinical Trial Technologies
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach ... Read More
-
Diabetes Diagnostics
... at a CAGR of 8.6% over the analysis period 2023-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of ... Read More
Research Assistance
